Form 4: Credo CEO Sells Shares Under 10b5-1 Plan

Credo Technology Group Holding Ltd's President and CEO, William Joseph Brennan, sold 168,433 ordinary shares through a pre-arranged 10b5-1 trading plan.

Summary

• William Joseph Brennan, President & Chief Executive Officer and Director of Credo Technology Group Holding Ltd (CRDO), reported sales of ordinary shares.
• The transactions occurred on August 1, 2025.
• A total of 168,433 ordinary shares were disposed of, comprising 48,442 shares held directly and 119,991 shares held indirectly through The Brennan Family Trust, DTD 09/06/2002.
• Direct share sales were executed at weighted average prices ranging from $103.5632 to $110.0481 per share.
• Indirect share sales were executed at weighted average prices ranging from $103.5634 to $110.048 per share.
• All sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.
• Following these transactions, William Joseph Brennan beneficially owns 393,338 direct ordinary shares and 2,061,978 indirect ordinary shares through The Brennan Family Trust.

Sentiment

Score: 5

Explanation: The filing reports pre-scheduled insider share sales under a 10b5-1 plan, which is a routine liquidity event and generally considered neutral unless the volume is exceptionally high or the timing suggests otherwise. The sales occurred at relatively high price points.

Positives

• The share sales were executed at relatively high price points, ranging from $103.56 to $110.05 per share.
• The transactions were pre-scheduled under a Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new negative information.

Negatives

• President and CEO William Joseph Brennan sold a significant number of shares, totaling 168,433, which reduces his direct and indirect ownership stake.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even if pre-planned, could lead to minor negative sentiment, but the execution under a 10b5-1 plan mitigates concerns about opportunistic selling based on non-public information.

Key Dates

Recommendation

The filing is a routine Form 4 disclosing pre-scheduled insider share sales under a 10b5-1 plan. While insider selling can sometimes be viewed negatively, the pre-arranged nature of these transactions suggests a planned liquidity event rather than a reaction to new material non-public information. Therefore, this filing alone does not provide sufficient new information to alter an investment thesis, warranting a 'hold' recommendation.

Keywords

Credo Technology, CRDO, insider trading, Form 4, stock sale, CEO, 10b5-1 plan, beneficial ownership